Paranoia

feeling effect

valenceadversefrequencyuncommontemporalacute

AI-inferred — this entry was drafted by AI and has not yet been verified against primary sources. A sourced revision is planned.

Paranoia is an acute belief that one is being watched, followed, or targeted when no such threat exists.

As a drug effect it is dose-proportional and eases as the substance wears off, distinguishing it from a standing paranoid disorder. It ranges from vague, nagging suspicion to an overwhelming certainty of threat that can drive dangerous behavior.

Paranoia is an uncommon but serious adverse effect reported across several drug classes. It is most commonly induced at moderate to high doses under cannabinoids such as THJ-018, JWH-018, and 5F-AKB48, and under stimulants such as 2-FA, 3,4-CTMP, and 4-FMA. It also appears under psychedelics such as LSD, psilocybin mushrooms, and 2,5-DMA, and in its most disorienting form under deliriants such as Datura and Benzydamine.

phenomenology

Paranoia is felt as a pervasive sense of threat without a verifiable source: attention locks onto ambiguous cues — a glance, a sound, a passing stranger — and reads them as confirmation of danger. Thoughts circle back to the same suspected threat, and rational challenge brings little relief.

It comes with a racing heart, muscle tension, and a hypervigilance that keeps the body primed to act. Attending to the suspicion deepens it; each ordinary detail becomes new evidence. At high doses, particularly under deliriants, it can solidify into full delusional conviction.

mechanism

Paranoia arises through different pathways depending on the drug class:

Cannabinoids — act on CB1 receptors in threat-processing regions; synthetic cannabinoids carry substantially higher risk than plant-derived preparations.
Stimulants — elevate dopamine in salience circuitry, causing neutral stimuli to feel significant and threatening.
Psychedelics — act on 5-HT2A receptors, loosening interpretive filters; threat schemas can dominate when the experience becomes destabilizing.
Deliriants — produce a confusional state in which paranoid content appears alongside hallucinations and disorientation.

How much each pathway contributes in a given case is not fully understood.

safety

Paranoia has driven dangerous behavior — attempts to flee, self-harm, or harm others — when the conviction of threat becomes overwhelming.

If it happens — move to a quiet, familiar space with trusted people. Do not be alone. Breathe slowly and repeat: this is the substance, it will pass. Do not act on the paranoid belief — no confrontations, no leaving.
Seek help if — the person cannot be redirected, becomes physically aggressive, attempts to flee into traffic or other hazards, or paranoia persists well beyond the expected effect window.
Higher risk — a personal or family history of psychosis; synthetic cannabinoids and high-dose stimulants carry the greatest risk of triggering an episode that outlasts the drug.

variability

Who experiences it, and how strongly, varies widely. Higher doses raise both likelihood and intensity across all classes; synthetic cannabinoids and stimulants at high doses present the greatest risk.

It is more likely in unfamiliar settings, under social stress, or with unresolved fear going in — especially under cannabinoids and psychedelics — and in people with a suspicious disposition or prior history of paranoid reactions. Going in already mistrustful tends to be self-fulfilling. A familiar environment, trusted company, and lower doses reduce it.